To directly address the hypothesis that the COX-1 inhibition component of NSAIDs reduces damage caused by MI (shifts the balance towards non fatal MI), the case-fatality effect of NSAIDs individually according to their degree of COX-1 and COX-2 inhibition needs to be assessed.
Obesity and smoking also remained independent risk factors for case fatality when their effect was studied together in a multivariate model adjusted with the effect of alcohol abuse, age (continuos variable), sex and causative organism.
This might be explained by the fact that most alcohol abusers were also smokers, and the effect on case fatality may thus result from smoking, not alcohol itself.
One-way sensitivity analyses were conducted for key parameters across all comparisons including: hospitalisation and rectal treatment costs; disease incidence rates; neurological sequelae incidence rates; untreated case fatality rates; the treatment effect of the rectal formulations on mortality and long-term disability; and the life tables used within the DALY calculations (Table 1).
We utilized Swedish nationwide registers to study breast cancer incidence and case fatality to disentangle the effect of socioeconomic position (SEP) and immigration from the trends in native Swedes.
This null scenario was determined by back calculating incidence and case fatality rates using intervention effect sizes and current coverage rates (that is, epidemiological rates are adjusted upwards to reflect the absence of any effective intervention).
This model allows the user to simulate the effects of an intervention (either risk factor modification, or therapy) by changing case fatality rates and observing the effect on mortality, morbidity and costs for up to 30 years.
Univariate and multivariate analyses revealed no significant effect on case fatality rate when a macrolide/β-lactam regimen was used as initial therapy.
With respect to this possibility, CD14 and TLR4 polymorphisms could even have a positive effect on case fatality rate of IMD.
We assumed that mortality from coronary heart disease would change by the same amount and that reducing trans fatty acids would have no effect on case fatality.
However, a significant seasonal effect on case fatality was found, as reflected by the lowered death risk estimates (RR 0.78 0.84, regardless of the time point of follow-up) for cases diagnosed during autumn (Table 1, Figure 1A).
